Latest Ratios: P/E Ratio 22.1x · EV/EBITDA 7.2x · ROE 11.3%. (2020–2025 historical series)
Price-based multiples — how expensive the stock is relative to earnings, sales, book value, and cash flow
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|---|
| Market Cap | $178M | $166M | $75M | $49M | $50M | — | — |
| Enterprise Value | $938M | $926M | $698M | $575M | $487M | — | — |
| P/E Ratio → | 22.12 | 21.83 | 18.49 | 19.79 | 26.61 | — | — |
| P/S Ratio | 1.15 | 1.07 | 0.64 | 0.49 | 0.54 | — | — |
| P/B Ratio | 3.33 | 3.29 | 0.90 | 1.04 | 1.00 | — | — |
| P/FCF | 1.98 | 1.85 | 2.13 | 0.89 | 0.97 | — | — |
| P/OCF | 1.98 | 1.85 | 1.27 | 0.89 | 0.97 | — | — |
P/E links to full P/E history page with 30-year chart
Enterprise-value multiples — capital-structure-neutral measures of total business value
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|---|
| EV / Revenue | — | 5.97 | 5.97 | 5.76 | 5.26 | — | — |
| EV / EBITDA | 7.18 | 7.09 | 7.31 | 7.47 | 6.18 | — | — |
| EV / EBIT | 11.13 | 10.99 | 11.61 | 12.59 | 12.93 | — | — |
| EV / FCF | — | 10.28 | 19.77 | 10.46 | 9.56 | — | — |
Margins and return-on-capital ratios measuring operating efficiency
Full margin charts and quarterly trend are on the Earnings History page
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|---|
| Gross Margin | 30.1% | 30.1% | 87.0% | 85.0% | 85.2% | 86.9% | 87.7% |
| Operating Margin | 54.4% | 54.4% | 52.4% | 47.5% | 54.0% | 42.2% | 47.0% |
| Net Profit Margin | 4.9% | 4.9% | 3.5% | 2.5% | 2.0% | 6.1% | 14.1% |
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|---|
| ROE | 11.3% | 11.3% | 6.3% | 5.2% | 4.4% | 22.0% | 88.6% |
| ROA | 0.9% | 0.9% | 0.6% | 0.4% | 0.3% | 1.0% | 2.3% |
| ROIC | 8.3% | 8.3% | 7.2% | 6.7% | 7.5% | 5.5% | — |
| ROCE | 10.3% | 10.3% | 9.0% | 8.4% | 9.2% | 6.9% | 7.7% |
Solvency and debt-coverage ratios — lower is generally safer
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|---|
| Debt / Equity | 15.66 | 15.66 | 8.04 | 11.38 | 9.26 | 14.38 | 36.42 |
| Debt / EBITDA | 6.06 | 6.06 | 7.03 | 6.99 | 5.81 | 7.81 | 7.36 |
| Net Debt / Equity | — | 15.03 | 7.46 | 11.12 | 8.85 | 13.63 | 35.10 |
| Net Debt / EBITDA | 5.82 | 5.82 | 6.53 | 6.83 | 5.55 | 7.40 | 7.09 |
| Debt / FCF | — | 8.44 | 17.64 | 9.57 | 8.58 | 10.67 | 12.61 |
| Interest Coverage | 1.65 | 1.65 | 1.79 | 1.80 | 1.77 | 1.39 | 1.50 |
Short-term solvency ratios and asset-utilisation metrics
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|---|
| Current Ratio | 5.47 | 5.47 | 7.37 | 4.66 | 6.46 | 4.13 | 7.00 |
| Quick Ratio | 5.47 | 5.47 | 7.37 | 4.66 | 6.46 | 4.13 | 7.00 |
| Cash Ratio | 1.42 | 1.42 | 2.58 | 0.72 | 1.47 | 1.27 | 1.35 |
| Asset Turnover | — | 0.18 | 0.15 | 0.16 | 0.17 | 0.15 | 0.16 |
| Inventory Turnover | — | — | — | — | — | — | — |
| Days Sales Outstanding | — | — | — | — | — | — | — |
Earnings, FCF, buyback, and dividend yields — total returns to shareholders
Full dividend history and growth charts are on the Dividend History page
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|---|
| Dividend Yield | 4.5% | 4.6% | 5.4% | 5.8% | 1.3% | — | — |
| Payout Ratio | 100.8% | 100.8% | 98.5% | 115.1% | 34.4% | 28.4% | — |
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|---|
| Earnings Yield | 4.5% | 4.6% | 5.4% | 5.1% | 3.8% | — | — |
| FCF Yield | 50.5% | 54.1% | 47.1% | 111.8% | 102.7% | — | — |
| Buyback Yield | 0.4% | 0.4% | 3.3% | 0.1% | 0.0% | — | — |
| Total Shareholder Yield | 4.9% | 5.0% | 8.7% | 5.9% | 1.3% | — | — |
| Shares Outstanding | — | $13M | $7M | $6M | $6M | $6M | $6M |
Includes 30+ ratios · 6 years · Updated daily
Live VCP patterns, Cup & Handle overlays, support/resistance, and AI trade plans.
High-probability breakout stocks crossing their pivot across 5 pattern engines.
DCF models, multiple analysis, and analyst estimates.
10-year return with dividends reinvested.
Compare growth, multiples, and margins vs sector.
Quick answers to the most common questions about buying STRW stock.
Strawberry Fields REIT, Inc.'s current P/E ratio is 22.1x. The historical average is 21.7x. This places it at the 75th percentile of its historical range.
Strawberry Fields REIT, Inc.'s current EV/EBITDA is 7.2x. This enterprise value multiple compares the company's total value (equity + debt - cash) to its EBITDA. The historical average is 7.0x.
Strawberry Fields REIT, Inc.'s return on equity (ROE) is 11.3%. The historical average is 23.0%.
Based on historical data, Strawberry Fields REIT, Inc. is trading at a P/E of 22.1x. This is at the 75th percentile of its historical P/E range. Compare with industry peers and growth rates for a complete picture.
Strawberry Fields REIT, Inc.'s current dividend yield is 4.53% with a payout ratio of 100.8%.
Strawberry Fields REIT, Inc. has 30.1% gross margin and 54.4% operating margin. Operating margin above 20% indicates strong pricing power and cost efficiency.
Strawberry Fields REIT, Inc.'s Debt/EBITDA ratio is 6.1x, indicating high leverage. A ratio above 4x may signal elevated financial risk.
Key Metrics
Top Statement Risk
Operator credit and regulatory
Metrics are mathematically derived from official filings.
Small Cap Discount Reflects Illiquidity
Based on the provided financial data, STRW's P/FFO multiple of 3.79 as of 2026Q1 suggests a significant valuation discount compared to broader healthcare REIT peers, likely reflecting the market's skepticism toward its geographic concentration and the inherent risks associated with its smaller market capitalization.
The low P/FFO multiple appears to indicate that investors are pricing in a risk premium for the company's heavy reliance on regional skilled nursing assets. While this valuation may suggest an attractive entry point, it warrants further investigation into whether the discount is justified by the potential for operator-level credit volatility or if it represents a mispricing of the company's growth potential.
Margin Volatility Masks Operational Efficiency
According to quarterly reports, NOI margins have experienced extreme fluctuations, dropping from 89.8% in 2025Q1 to 32.8% in 2026Q1, which suggests that the company's property-level profitability is highly sensitive to either rising operating expenses or shifts in lease accounting classifications.
The sharp contraction in margins implies that the company's recent aggressive acquisition phase may be introducing integration costs or operational inefficiencies that are not yet fully stabilized. Investors should monitor whether these margin pressures are transitory or if they indicate a structural decline in the profitability of the underlying skilled nursing portfolio.
Conservative Payout Supports Growth Reinvestment
As reported in financial statements, the FFO payout ratio remained remarkably low at 7.6% in 2026Q1, indicating that the company is retaining the vast majority of its distributable cash flow to fund ongoing portfolio expansion rather than prioritizing immediate dividend yield for shareholders.
This low payout ratio provides a substantial buffer for dividend sustainability, even in the event of operator-level rent defaults or regulatory-driven revenue shocks. The strategy appears to favor long-term capital appreciation through asset growth, though it may frustrate income-focused investors seeking higher immediate returns.
Conservative Leverage Amidst Rapid Expansion
Based on the provided financial data, STRW maintains a debt-to-equity ratio of 15.58 as of 2026Q1, which appears remarkably conservative for a REIT in an active acquisition phase, suggesting that management is prioritizing balance sheet stability while navigating the capital-intensive nature of healthcare real estate.
The low leverage profile provides the company with significant dry powder to pursue further acquisitions, potentially insulating it from the immediate pressures of a rising interest rate environment. However, the reliance on debt to fund its 79-property portfolio requires careful monitoring of interest coverage ratios, which have remained relatively tight at 1.72.
Misapplication of Standard P/E Multiples
The market's reliance on standard P/E ratios to value STRW is fundamentally flawed, as reported in financial statements, because it fails to account for the massive non-cash depreciation charges that are inherent to the REIT business model and distort net income.
Using P/E obscures the true cash-generating capacity of the portfolio, leading to a misleading assessment of the company's valuation. Analysts should instead focus on P/FFO or P/AFFO, which adjust for these non-cash items and provide a more accurate reflection of the REIT's ability to sustain its dividend and fund future growth.